LEU Q2 Deep Dive: Backlog Growth and Expansion Plans Meet Margin Pressures

Nuclear fuel supplier Centrus Energy (NYSE:LEU) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 14% year on year to $176.1 million. Its non-GAAP profit of $0.77 per share was 4.9% below analysts’ consensus estimates.

Is now the time to buy LEU? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Centrus Energy’s second quarter saw revenue growth driven by higher commercial activity in both its low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) markets, but profitability came under pressure as operating margin contracted sharply year-on-year. Management pointed to increased spending on workforce expansion, manufacturing readiness, and advanced technology costs as key factors behind the margin decline. CEO Amir Vexler acknowledged the variability in quarterly results and highlighted that increased order momentum and backlog growth were supported by strong demand in both commercial and government markets. CFO Todd Tinelli attributed the reduced net income to higher stock compensation and advanced technology expenses, partially offset by investment income gains.

Looking forward, Centrus Energy’s guidance rests on expectations of sustained demand for nuclear fuel—particularly as regulatory changes and supply chain initiatives advance new reactor projects in the U.S. and abroad. Management emphasized ongoing investments in expanding centrifuge production capacity and strengthening supply chain partnerships, aiming to derisk long-term capital commitments. Vexler stated, “We are reaffirming our 2026 annual guidance for total company revenue of $450 million to $500 million,” and highlighted the planned completion of the first centrifuge at Oak Ridge as a major operational milestone. The company also anticipates further growth in its backlog as it finalizes more definitive contracts with utilities and advanced reactor developers, while maintaining focus on cost efficiencies and accelerating hiring at key facilities.

Key Insights from Management’s Remarks

Management attributed the quarter’s performance to strong demand signals across all addressable markets, higher commercial backlog, and continued investment in manufacturing expansion and supply chain resilience.

• Commercial backlog expansion: Centrus reported a meaningful increase in its order backlog, now extending to 2040, supported by new definitive agreements for both LEU and HALEU. The backlog grew as customers sought to secure long-term nuclear fuel supply amid tightening market conditions and regulatory changes.
• HALEU market traction: The company signed a letter of intent with Oklo and a definitive offtake agreement with X-energy to supply HALEU, positioning itself as a preferred supplier for advanced reactor projects. These contracts often include prepayments, providing nondilutive funding for expansion and highlighting Centrus’s first-mover advantage in the HALEU segment.
• DOE enrichment award: Centrus secured a $900 million task order from the U.S. Department of Energy (DOE), supporting the build-out of large-scale centrifuge capacity. This non-debt funding helps derisk expansion and underscores Centrus’s unique role in meeting national security and commercial fuel needs.
• Cost and margin pressures: Operating margin was impacted by increased SG&A and advanced technology costs, particularly related to workforce additions, manufacturing readiness, and security training at facilities in Piketon and Oak Ridge. Management expects some of these costs to persist as ramp-up activities continue.
• Supply chain and efficiency initiatives: Centrus locked in contracts with approximately 75% of its critical suppliers and is pursuing further cost savings through partnerships (notably with Palantir) and internal process improvements. These efforts are intended to stabilize costs and accelerate lead times for future production.

Drivers of Future Performance

Centrus’s outlook is shaped by persistent demand for nuclear fuel, continued expansion of manufacturing capacity, and ongoing efforts to secure long-term supply contracts and cost efficiencies.

• Backlog growth and customer commitments: Management expects continued growth in the commercial backlog as more utilities and reactor developers opt for definitive long-term contracts. The removal of financial contingencies has made Centrus a lower-risk partner, and increasing engagement with utilities is expected to drive incremental orders.
• Manufacturing scale-up and workforce expansion: The planned completion of the first centrifuge at Oak Ridge in 2026 and accelerated hiring at Piketon are foundational to Centrus’s capacity build-out. These developments aim to enable earlier and more reliable delivery of enrichment services, supporting both LEU and HALEU markets.
• Cost management and supply chain resilience: Ongoing partnerships with technology and engineering firms, such as Palantir, as well as long-term supplier agreements, are expected to yield cost savings and efficiency gains. However, management cautions that some elevated costs tied to expansion and advanced technology will continue in the near term, posing pressure on margins.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will closely monitor (1) the pace of workforce expansion and the milestone of completing the first Oak Ridge centrifuge, (2) new contract signings with utilities and reactor developers that expand the backlog, and (3) execution of supply chain and cost-saving initiatives to protect margins. The ability to convert letters of intent into definitive agreements and maintain momentum in the HALEU and LEU segments will be critical.

Centrus Energy currently trades at $179.37, down from $189.32 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.